Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Neuren Pharmaceuticals Limited NURPF

Set alert

Price alert · NURPF

All alert types
14.28 USD 0.00 0.00%

At close · Oct 29

13.94 Day range 13.94
8.22 52-week range 17.00
YTD
+10.59%
1 year
+6.95%
Open
13.94
Prev close
14.28
Mkt cap
1.81B
Vol
265
Avg vol
477
EPS
0.10
P/E
142.77
More statistics
Low
13.94
High
13.94
Earnings
Aug 25, 2026

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NURPF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

215.85 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 80.6×
FY 2016: -7.5×FY 2017: 90.7×FY 2018: 49.4×FY 2019: -22.1×FY 2020: -14.5×FY 2021: -58.0×FY 2022: 5329×FY 2023: 20.1×FY 2024: 11.2×FY 2025: 80.6×
FY 2016 5y median 20.1× FY 2025
P/S 38.4×
FY 2016: 28.8×FY 2017: 476×FY 2018: 10.8×FY 2019: 493×FY 2020: 186×FY 2021: 141×FY 2022: 69.2×FY 2023: 13.7×FY 2024: 7.4×FY 2025: 38.4×
FY 2016 5y median 38.4× FY 2025
P/B 7.3×
FY 2016: 21.7×FY 2017: 18.3×FY 2018: 6.1×FY 2019: 17.6×FY 2020: 5.5×FY 2021: 11.5×FY 2022: 24.2×FY 2023: 15.4×FY 2024: 4.4×FY 2025: 7.3×
FY 2016 5y median 11.5× FY 2025
P/FCF 19.8×
FY 2016: -7.3×FY 2017: -53.7×FY 2018: 23.7×FY 2019: -20.8×FY 2020: -16.5×FY 2021: -45.3×FY 2022: 281×FY 2023: 17.1×FY 2024: -142×FY 2025: 19.8×
FY 2016 5y median 17.1× FY 2025
EV/EBITDA 112×
FY 2016: -6.2×FY 2017: -49.3×FY 2018: 23.9×FY 2019: -20.4×FY 2020: -12.4×FY 2021: -50.5×FY 2022: -1339×FY 2023: 15.8×FY 2024: 8.9×FY 2025: 112×
FY 2016 5y median 8.9× FY 2025
EV/Sales 38.3×
FY 2016: 27.2×FY 2017: 468×FY 2018: 9.2×FY 2019: 465×FY 2020: 153×FY 2021: 130×FY 2022: 66.4×FY 2023: 13.6×FY 2024: 7.4×FY 2025: 38.3×
FY 2016 5y median 38.3× FY 2025
FCF Yield 5.1%
FY 2016: -13.7%FY 2017: -1.9%FY 2018: 4.2%FY 2019: -4.8%FY 2020: -6.1%FY 2021: -2.2%FY 2022: 0.4%FY 2023: 5.8%FY 2024: -0.7%FY 2025: 5.1%
FY 2016 5y median 0.4% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 97.5%FY 2017: 87.6%FY 2018: 56.4%FY 2019: 99.2%FY 2020: 99.2%FY 2021: 99.7%FY 2022: 99.9%FY 2023: 88.5%FY 2024: 84.8%FY 2025: 100.0%
FY 2016 5y median 99.7% FY 2025
Operating Margin 34.1%
FY 2016: -481.5%FY 2017: -1062.4%FY 2018: 41.6%FY 2019: -2337.6%FY 2020: -2311.3%FY 2021: -555.2%FY 2022: -11.0%FY 2023: 74.4%FY 2024: 67.4%FY 2025: 34.1%
FY 2016 5y median 34.1% FY 2025
Net Margin 47.1%
FY 2016: -381.4%FY 2017: 521.1%FY 2018: 22.0%FY 2019: -2185.1%FY 2020: -1282.1%FY 2021: -243.8%FY 2022: 1.3%FY 2023: 67.7%FY 2024: 65.5%FY 2025: 47.1%
FY 2016 5y median 47.1% FY 2025
ROE 9.0%
FY 2016: -287.2%FY 2017: 20.1%FY 2018: 12.5%FY 2019: -78.1%FY 2020: -38.0%FY 2021: -19.9%FY 2022: 0.4%FY 2023: 76.5%FY 2024: 39.0%FY 2025: 9.0%
FY 2016 5y median 9.0% FY 2025
ROIC 5.1%
FY 2016: -314.3%FY 2017: -46.0%FY 2018: 23.6%FY 2019: -79.9%FY 2020: -68.5%FY 2021: -31.8%FY 2022: 1.0%FY 2023: 64.4%FY 2024: 31.2%FY 2025: 5.1%
FY 2016 5y median 5.1% FY 2025
ROA 8.9%
FY 2016: -193.5%FY 2017: 18.3%FY 2018: 11.5%FY 2019: -75.1%FY 2020: -36.8%FY 2021: -19.5%FY 2022: 0.4%FY 2023: 63.3%FY 2024: 34.7%FY 2025: 8.9%
FY 2016 5y median 8.9% FY 2025

Growth (YoY)

Revenue -70.2%
FY 2016: 88.3%FY 2017: -80.0%FY 2018: 2117.1%FY 2019: -96.5%FY 2020: 44.8%FY 2021: 345.9%FY 2022: 355.2%FY 2023: 1493.7%FY 2024: -6.5%FY 2025: -70.2%
FY 2016 FY 2025
Operating Income -84.9%
FY 2016: 12.1%FY 2017: 55.8%FY 2018: 186.7%FY 2019: -299.0%FY 2020: -43.2%FY 2021: -7.1%FY 2022: 91.0%FY 2023: 10907.9%FY 2024: -15.2%FY 2025: -84.9%
FY 2016 FY 2025
EPS (diluted) -78.0%
FY 2016: -1675.0%FY 2017: 101.2%FY 2018: -12.0%FY 2019: -457.1%FY 2020: 21.9%FY 2021: 22.9%FY 2022: 102.1%FY 2023: 85614.3%FY 2024: -9.2%FY 2025: -78.0%
FY 2016 FY 2025
Free Cash Flow 1211.1%
FY 2016: 2.7%FY 2017: 54.9%FY 2018: 214.6%FY 2019: -283.1%FY 2020: 31.1%FY 2021: -23.5%FY 2022: 135.9%FY 2023: 5064.4%FY 2024: -106.1%FY 2025: 1211.1%
FY 2016 FY 2025

Financial Health

Current Ratio 76.6×
FY 2016: 3.0×FY 2017: 10.2×FY 2018: 13.5×FY 2019: 25.8×FY 2020: 33.1×FY 2021: 49.9×FY 2022: 25.8×FY 2023: 5.8×FY 2024: 8.7×FY 2025: 76.6×
FY 2016 5y median 25.8× FY 2025
Quick Ratio 76.6×
FY 2016: 3.5×FY 2017: 10.2×FY 2018: 13.5×FY 2019: 26.7×FY 2020: 33.1×FY 2021: 49.9×FY 2022: 25.8×FY 2023: 5.8×FY 2024: 8.4×FY 2025: 76.6×
FY 2016 5y median 25.8× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.2×
FY 2016: 0.4×FY 2017: 0.8×FY 2018: -4.4×FY 2019: 1.2×FY 2020: 2.7×FY 2021: 4.5×FY 2022: 55.7×FY 2023: -0.1×FY 2024: -0.0×FY 2025: -0.2×
FY 2016 5y median -0.0× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31